Target intelligence / Profile preview

Undecaprenyl pyrophosphate (UPP) (UPP)

Target
UPP
Molecular classification
Other, Lipid carrier, Isoprenoid
01

Overview

Undecaprenyl pyrophosphate (UPP), also known as C55-isoprenyl pyrophosphate, is an essential lipid carrier required for the synthesis of the bacterial cell wall (Manat et al., 2014, FEMS Microbiol Rev). It plays a pivotal role in transporting hydrophilic building blocks, such as peptidoglycan and teichoic acid precursors, across the hydrophobic cytoplasmic membrane to the external site of assembly (Scheffers & Pinho, 2005, Microbiol Mol Biol Rev). After delivering its cargo, UPP must be dephosphorylated into undecaprenyl phosphate (UP) by membrane-bound phosphatases to be recycled for further transport cycles (Siewert & Strominger, 1967, PNAS). This recycling step is the specific target of the antibiotic bacitracin, which forms a complex with UPP in the presence of divalent metal ions, effectively sequestering the carrier and halting cell wall production (Stone & Strominger, 1971, PNAS). Because the UPP cycle is indispensable for bacterial viability and lacks a direct human homolog, it is a highly validated target for antimicrobial drug development (Ling et al., 2015, Nature). Targeting this molecule is particularly effective against Gram-positive pathogens, though systemic use of drugs like bacitracin is limited by significant nephrotoxicity (Gallagher et al., 2011, Bioorg Med Chem). Other antibiotics, such as teixobactin, also target the lipid-linked intermediates of this pathway, highlighting its vulnerability as a therapeutic target.

Other names
C55-isoprenyl pyrophosphateUndecaprenyl diphosphateBactoprenol pyrophosphateC55-PPLipid pyrophosphate
02

Mechanism of action

Inhibition of undecaprenyl pyrophosphate dephosphorylation and sequestration of lipid-linked cell wall precursors

03

Biological functions

OtherCell wall synthesisLipid transportPeptidoglycan biosynthesis
04

Disease associations

Infection
05

Safety considerations

NephrotoxicityHypersensitivity reactionsLimited systemic bioavailabilityContact dermatitis
06

Interacting drugs

Bacitracin

4 more in the full profile.

07

Biomarkers

Bacterial growth inhibitionMinimum inhibitory concentration (MIC)Peptidoglycan synthesis rate

Beyond the preview

Go deeper on Undecaprenyl pyrophosphate (UPP) (UPP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Undecaprenyl pyrophosphate (UPP) (UPP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call